Evidence map›Paper›PMID 32746904›Full record

Trial reportBMC research notes2020

Fermented soy supplementation improves indicators of quality of life: a randomized, placebo-controlled, double-blind trial in adults experiencing heartburn.

Asmaa Fatani, Kadi Vaher, Daniela Rivero-Mendoza, Karima Alabasi, Wendy J Dahl

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC research notes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Asmaa FataniDepartment of Food Science and Human Nutrition, University of Florida, 359 FSHN Building, 572 Newell Drive, Gainesville, FL, USA.
Kadi VaherLallemand Bio-Ingredients, Akadeemia tee 21/3, Tallinn, 12618, Estonia.
Daniela Rivero-MendozaDepartment of Food Science and Human Nutrition, University of Florida, 359 FSHN Building, 572 Newell Drive, Gainesville, FL, USA.
Karima AlabasiDepartment of Food Science and Human Nutrition, University of Florida, 359 FSHN Building, 572 Newell Drive, Gainesville, FL, USA.
Wendy J DahlDepartment of Food Science and Human Nutrition, University of Florida, 359 FSHN Building, 572 Newell Drive, Gainesville, FL, USA. wdahl@ufl.edu.ORCID http://orcid.org/0000-0003-2061-4731
University of Florida · US

Funding

Danstar Ferment AG Lallemand P0109958
6 · The paper itself

Abstract

objectiveTo determine if fermented soy supplementation relieves heartburn and improves gastrointestinal symptoms and quality of life, a randomized, double-blind parallel study was conducted with adults experiencing mild or moderate heartburn. Participants consumed up to 3, 1 g sachets of flavored, Lactobacillus delbrueckii fermented with soy flour (n = 23) or placebo (maltodextrin) (n = 27) sachets per heartburn incident as needed for 3 weeks. Symptom intensity at 5, 15, and 30 min post-administration was assessed using a Likert-like scale. The Gastrointestinal Symptoms Rating Scale (GSRS) and Gastro-esophageal Reflux Disease Quality of Life Questionnaire (GERD-QOL) were administered at baseline, post-intervention and following a 1-week washout.

resultsNo significant differences between groups were seen for heartburn severity or frequency, GSRS syndromes, or GERD-QOL domains. However, individual QOL items related to inconvenience of taking medications, fear of eating, inability to concentrate at work, and disturbance of after-meal activities and rest improved with fermented soy compared to placebo. Frequency of heartburn, diarrhea, and bloating improved during washout vs. baseline for the fermented soy group compared to placebo. Lactobacillus delbrueckii fermented soy supplementation improved QOL indicators and may decrease heartburn occurrence over time vs. an acute effect; efficacy of daily intake and longer duration requires investigation.

Indexed as

Gastroesophageal RefluxQuality of LifeAdultDietary SupplementsDouble-Blind MethodHeartburnHumansSurveys and QuestionnairesTreatment OutcomeGastroesophageal refluxLactobacillusQuality of lifeSoybean

Identifiers

PMID32746904
PMCPMC7397630
OpenAlexW3046582641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.